Letermovir is an antiviral active pharmaceutical ingredient used to prevent cytomegalovirus (CMV) infections, particularly in immunocompromised patients such as those undergoing allogeneic stem cell transplants. It is a research compound developed for pharmaceutical manufacturing and supply.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 917389-32-3
Acetamide,N-[9-[[2-(acetyloxy)-1-[(acetyloxy)methyl]ethoxy]methyl]-6,9-dihydro-6-oxo-1H-purin-2-yl]-
antiviral active pharmaceutical ingredient
Isoprinosine
antiviral active pharmaceutical ingredient
Foscarnet
antiviral active pharmaceutical ingredient
Acyclovir alaninate
antiviral active pharmaceutical ingredient
Cefdinir
active pharmaceutical ingredient
Vemurafenib
active pharmaceutical ingredient
Lithium citrate
antidepressant pharmaceutical ingredient
PHENOTHIAZINE
Parent compound for antipsychotic drugs
2-[(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4H-quinazolin-4-yl]acetic acid
FWYSMLBETOMXAG-QHCPKHFHSA-N
COC1=C(C=C(C=C1)C(F)(F)F)N2[C@H](C3=C(C(=CC=C3)F)N=C2N4CCN(CC4)C5=CC(=CC=C5)OC)CC(=O)O